News
Since its launch in late March, Mounjaro sales have trebled. Winselow Tucker, president and general manager of Lilly in India ...
Eli Lilly’s diabetes and obesity management drug Mounjaro saw a sharp rise in sales for the third consecutive month, driven ...
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...
Eli Lilly's weight-loss and diabetes drug, Mounjaro, has experienced a 60% sales increase in India between April and May.
Eli Lilly & Co. sees 60% sales increase for weight-loss drug in India, tapping into growing demand for anti-obesity solutions ...
16h
TipRanks on MSNEli Lilly’s obesity drug sales rise in India, Bloomberg reportsEli Lilly (LLY) increased its sale of Mounjaro, its weight-loss and diabetes drug, by 60% in India in May from April, Satviki Sanjay of Bloomberg ...
2h
NDTV Profit on MSNObesity Drugs Pick Pace In India — Can Consumption Sector Withstand A $21 Billion Disruption? | Open InterestIn this edition of Open Interest, we look at how the focus on GLP-1 could reduce household dietary intake and grocery bills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results